Table 2 Cytogenetic abnormalities classified by CD27 and CD117 expression
From: Prognostic value of the expression of CD27 and CD117 in newly diagnosed multiple myeloma patients
CD27- CD117- | CD27- CD117+ | CD27+ CD117- | CD27+ CD117+ | P value | |
|---|---|---|---|---|---|
N = 48 | N = 41 | N = 42 | N = 29 | ||
1q21 gain\amplification | 33 (37.90%) | 19 (21.80%) | 26 (29.90%) | 9 (10.30%) | 0.006** |
Del (17/17p) | 7 (38.90%) | 5 (27.80%) | 6 (21.30%) | 0 (0.00%) | 0.218 |
t (4;14) | 10 (35.70%) | 4 (14.30%) | 12 (42.90%) | 2 (7.10%) | 0.047* |
t (14;16) | 21 (43.80%) | 11 (22.90%) | 13 (27.10%) | 3 (6.30%) | 0.019* |
Del (13) | 4 (21.10%) | 0 (0.00%) | 11 (57.90%) | 4 (21.10%) | 0.002** |
t (11;14) | 21 (28.80%) | 23 (31.50%) | 17 (23.30%) | 12 (16.40%) | 0.474 |
Negative | 2 (22.20%) | 1 (11.10%) | 1 (11.10%) | 5 (55.60%) | 0.315 |